Showing results (91-100 of 2,019) with videos related to
Sort By:
Pageof 202
Pediatric Infectious Disease|May 1, 1986
Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitisB L Congeni, J Bradley, M R HammerschlagExpert Review of Anti-Infective Therapy|April 29, 2025
Predicting the limit to ceftriaxone's use in gonorrhea treatment: impending resistance and logistical challengesSusannah F Vanderpool, Nardine Karam, Margaret R HammerschlagThe Pediatric Infectious Disease Journal|February 15, 2001
Failure to demonstrate Chlamydia pneumoniae in cardiovascular tissue from children with Kawasaki diseaseM R Hammerschlag, J Boman, A H RowleyJournal of Neurochemistry|October 1, 1983
Fast-transported glycoproteins and nonglycosylated proteins contain sulfateG C Stone, R Hammerschlag, J A BobinskiJournal of Clinical Microbiology|August 1, 1992
Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniaeP M Roblin, W Dumornay, M R HammerschlagAntimicrobial Agents and Chemotherapy|January 18, 2002
Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection ModelAndrei Kutlin, Patricia M Roblin, Margaret R HammerschlagAntimicrobial Agents and Chemotherapy|September 1, 1989
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR)K Chirgwin, P M Roblin, M R HammerschlagInternational Journal of Antimicrobial Agents|June 7, 2003
In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniaePatricia M Roblin, Tamara Reznik, Margaret R HammerschlagBrain Research|February 2, 1981
An increase in smooth endoplasmic reticulum and a decrease in Golgi apparatus occur with ionic conditions that block initiation of fast axonal transportJ D Lindsey, R Hammerschlag, M H EllismanJournal of Neurochemistry|January 1, 1989
Metalloendoprotease inhibitors block fast axonal transportR Hammerschlag, F A Bolen, G C StonePageof 202